vs

Side-by-side financial comparison of Prelude Therapeutics Inc (PRLD) and Solid Power, Inc. (SLDP). Click either name above to swap in a different company.

Prelude Therapeutics Inc is the larger business by last-quarter revenue ($6.5M vs $3.6M, roughly 1.8× Solid Power, Inc.). On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs -18.6%).

PRLD vs SLDP — Head-to-Head

Bigger by revenue
PRLD
PRLD
1.8× larger
PRLD
$6.5M
$3.6M
SLDP
Growing faster (revenue YoY)
PRLD
PRLD
+135.3% gap
PRLD
116.7%
-18.6%
SLDP

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
PRLD
PRLD
SLDP
SLDP
Revenue
$6.5M
$3.6M
Net Profit
$-19.7M
Gross Margin
Operating Margin
-314.1%
-730.1%
Net Margin
-303.5%
Revenue YoY
116.7%
-18.6%
Net Profit YoY
38.9%
EPS (diluted)
$-0.26
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRLD
PRLD
SLDP
SLDP
Q4 25
$3.6M
Q3 25
$6.5M
$3.7M
Q2 25
$6.5M
Q1 25
$6.0M
Q4 24
$4.5M
Q3 24
$3.0M
$4.7M
Q2 24
$5.1M
Q1 24
$6.0M
Net Profit
PRLD
PRLD
SLDP
SLDP
Q4 25
Q3 25
$-19.7M
$-25.9M
Q2 25
$-25.3M
Q1 25
$-15.2M
Q4 24
Q3 24
$-32.3M
$-22.4M
Q2 24
$-22.3M
Q1 24
$-21.2M
Operating Margin
PRLD
PRLD
SLDP
SLDP
Q4 25
-730.1%
Q3 25
-314.1%
-654.4%
Q2 25
-398.9%
Q1 25
-399.4%
Q4 24
-561.1%
Q3 24
-1145.9%
-593.2%
Q2 24
-530.8%
Q1 24
-433.1%
Net Margin
PRLD
PRLD
SLDP
SLDP
Q4 25
Q3 25
-303.5%
-693.1%
Q2 25
-390.7%
Q1 25
-251.8%
Q4 24
Q3 24
-1075.7%
-482.0%
Q2 24
-438.9%
Q1 24
-356.2%
EPS (diluted)
PRLD
PRLD
SLDP
SLDP
Q4 25
$-0.15
Q3 25
$-0.26
$-0.14
Q2 25
$-0.14
Q1 25
$-0.08
Q4 24
$-0.16
Q3 24
$-0.43
$-0.13
Q2 24
$-0.13
Q1 24
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRLD
PRLD
SLDP
SLDP
Cash + ST InvestmentsLiquidity on hand
$55.0M
$250.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$58.5M
$415.7M
Total Assets
$94.8M
$455.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRLD
PRLD
SLDP
SLDP
Q4 25
$250.8M
Q3 25
$55.0M
$251.2M
Q2 25
$230.9M
Q1 25
$240.9M
Q4 24
$118.2M
Q3 24
$153.6M
$132.0M
Q2 24
$140.5M
Q1 24
$146.6M
Stockholders' Equity
PRLD
PRLD
SLDP
SLDP
Q4 25
$415.7M
Q3 25
$58.5M
$381.2M
Q2 25
$370.6M
Q1 25
$397.1M
Q4 24
$410.3M
Q3 24
$156.4M
$439.4M
Q2 24
$456.8M
Q1 24
$479.4M
Total Assets
PRLD
PRLD
SLDP
SLDP
Q4 25
$455.1M
Q3 25
$94.8M
$416.1M
Q2 25
$398.0M
Q1 25
$419.4M
Q4 24
$448.3M
Q3 24
$197.2M
$470.9M
Q2 24
$492.6M
Q1 24
$516.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRLD
PRLD
SLDP
SLDP
Operating Cash FlowLast quarter
$-19.1M
$-18.4M
Free Cash FlowOCF − Capex
$-23.0M
FCF MarginFCF / Revenue
-633.0%
Capex IntensityCapex / Revenue
0.0%
126.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-83.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRLD
PRLD
SLDP
SLDP
Q4 25
$-18.4M
Q3 25
$-19.1M
$-14.3M
Q2 25
$-14.4M
Q1 25
$-26.3M
Q4 24
$-13.9M
Q3 24
$-27.3M
$-9.9M
Q2 24
$-11.1M
Q1 24
$-29.1M
Free Cash Flow
PRLD
PRLD
SLDP
SLDP
Q4 25
$-23.0M
Q3 25
$-14.8M
Q2 25
$-17.1M
Q1 25
$-28.6M
Q4 24
$-18.6M
Q3 24
$-27.4M
$-12.6M
Q2 24
$-15.5M
Q1 24
$-33.1M
FCF Margin
PRLD
PRLD
SLDP
SLDP
Q4 25
-633.0%
Q3 25
-397.6%
Q2 25
-264.2%
Q1 25
-476.1%
Q4 24
-416.5%
Q3 24
-912.0%
-271.5%
Q2 24
-305.8%
Q1 24
-556.3%
Capex Intensity
PRLD
PRLD
SLDP
SLDP
Q4 25
126.5%
Q3 25
0.0%
15.3%
Q2 25
41.5%
Q1 25
39.1%
Q4 24
105.5%
Q3 24
2.1%
59.7%
Q2 24
86.8%
Q1 24
68.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons